Rexinoid therapy bypasses the differentiation block associated with acute promyelocytic leukemia harboring the PLZF/RARα rearrangement.

被引：0
|
作者：
Guidez, F
Altucci, L
Xu, K
Rossin, A
Wilhelm, E
Culligan, DJ
Solomon, E
Gronemeyer, H
Zelent, A
Grimwade, D
机构：
[1] Inst Canc Res, Leukaemia Res Fund Ctr, London SW3 6JB, England
[2] Aberdeen Royal Infirm, Dept Hematol, Aberdeen, Scotland
[3] IGBMC, Illkirch Graffenstaden, France
[4] GKT Sch Med, Div Med & Mol Genet, London, England
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3192
引用
收藏
页码：766A / 767A
页数：2
相关论文
共 50 条
  • [21] Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARα acute promyelocytic leukemia (APML)
    George, B
    Poonkuzhali, B
    Srivastava, VM
    Chandy, M
    Srivastava, A
    ANNALS OF HEMATOLOGY, 2005, 84 (06) : 406 - 408
  • [22] Gamma-catenin plays a major role in the leukemogenesis induced by the acute promyelocytic leukemia-associated translocation products, PML/RAR and PLZF/RAR (X-RAR).
    Zheng, XM
    Beissert, T
    Kukoc-Zivojnov, N
    Guel, H
    Ottmann, OG
    Hoelzer, D
    Mitrou, P
    Puccetti, E
    Ruthardt, M
    BLOOD, 2003, 102 (11) : 221A - 221A
  • [23] Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARα acute promyelocytic leukemia (APML)
    B. George
    B. Poonkuzhali
    V. M. Srivastava
    M. Chandy
    A. Srivastava
    Annals of Hematology, 2005, 84 : 406 - 408
  • [24] RARα-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia
    Guidez, Fabien
    Parks, Sarah
    Wong, Henna
    Jovanovic, Jelena V.
    Mays, Ashley
    Gilkes, Amanda F.
    Mills, Kenneth I.
    Guillemin, Marie-Claude
    Hobbs, Robin M.
    Pandolfi, Pier Paolo
    de The, Hugues
    Solomon, Ellen
    Grimwade, David
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (47) : 18694 - 18699
  • [25] The acute promyelocytic leukemia-associated fusion proteins PML/RAR and PLZF/RAR interact with PU.1 and inactivate its transcriptional function.
    Seshire, A
    Beissert, T
    Hoelzer, D
    Ruthardt, M
    Puccetti, E
    BLOOD, 2005, 106 (11) : 459A - 459A
  • [26] Phenylarsine Oxide Can Induce Degradation of PLZF-RARα Variant Fusion Protein of Acute Promyelocytic Leukemia
    Hussain, Liaqat
    Maimaitiyiming, Yasen
    Su, Li De
    Wang, Qian Qian
    Naranmandura, Hua
    CHEMICAL RESEARCH IN TOXICOLOGY, 2019, 32 (04) : 548 - 550
  • [27] Characterization of histone deacetylase recruiting domains in the acute promyelocytic leukemia specific PLZF/RARα fusion protein.
    Puccetti, E
    Ottmann, OG
    Hoelzer, D
    Ruthardt, M
    BLOOD, 1998, 92 (10) : 212A - 212A
  • [28] PLZF-RARα, NPM1-RARα, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review
    Sobas, Marta
    Talarn-Forcadell, Maria Carme
    Martinez-Cuadron, David
    Escoda, Lourdes
    Garcia-Perez, Maria J.
    Mariz, Jose
    Mela-Osorio, Maria J.
    Fernandez, Isolda
    Alonso-Dominguez, Juan M.
    Cornago-Navascues, Javier
    Rodriguez-Macias, Gabriela
    Amutio, Maria E.
    Rodriguez-Medina, Carlos
    Esteve, Jordi
    Sokol, Agnieszka
    Murciano-Carrillo, Thais
    Calasanz, Maria J.
    Barrios, Manuel
    Barragan, Eva
    Sanz, Miguel A.
    Montesinos, Pau
    CANCERS, 2020, 12 (05)
  • [29] The aberrant fusion protiens PML-RAR-α and PLZF-RAR-α contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia.
    Yang, R
    Meuller, C
    Park, DJ
    Koeffler, HP
    BLOOD, 1999, 94 (10) : 75A - 75A
  • [30] The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain
    Sitterlin, D
    Tiollais, P
    Transy, C
    ONCOGENE, 1997, 14 (09) : 1067 - 1074
12345